NCT05908721View on ClinicalTrials.gov

Study of CM310 in Patients With Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 23, 2023

Primary Completion Date

December 10, 2023

Study Completion Date

December 10, 2023

Conditions
Allergic Rhinitis
Interventions
BIOLOGICAL

CM310

IL-4Rα monoclonal antibody

Trial Locations (1)

Unknown

Beijing Tong-Ren hospital, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT05908721 - Study of CM310 in Patients With Allergic Rhinitis | Biotech Hunter | Biotech Hunter